Experience with enzyme replacement therapy in children with late-onset Pompe disease diagnosed via newborn screening in the United States
Publication
, Conference
Huggins, E; Nading, E; Makhijani, N; Blount, J; Holland, M; Case, L; Kishnani, P
Published in: Molecular Genetics and Metabolism
February 2024
Duke Scholars
Published In
Molecular Genetics and Metabolism
DOI
ISSN
1096-7192
Publication Date
February 2024
Volume
141
Issue
2
Start / End Page
107886 / 107886
Publisher
Elsevier BV
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Huggins, E., Nading, E., Makhijani, N., Blount, J., Holland, M., Case, L., & Kishnani, P. (2024). Experience with enzyme replacement therapy in children with late-onset Pompe disease diagnosed via newborn screening in the United States. In Molecular Genetics and Metabolism (Vol. 141, pp. 107886–107886). Elsevier BV. https://doi.org/10.1016/j.ymgme.2023.107886
Huggins, Erin, Erica Nading, Neelam Makhijani, Janet Blount, Maggie Holland, Laura Case, and Priya Kishnani. “Experience with enzyme replacement therapy in children with late-onset Pompe disease diagnosed via newborn screening in the United States.” In Molecular Genetics and Metabolism, 141:107886–107886. Elsevier BV, 2024. https://doi.org/10.1016/j.ymgme.2023.107886.
Huggins E, Nading E, Makhijani N, Blount J, Holland M, Case L, et al. Experience with enzyme replacement therapy in children with late-onset Pompe disease diagnosed via newborn screening in the United States. In: Molecular Genetics and Metabolism. Elsevier BV; 2024. p. 107886–107886.
Huggins, Erin, et al. “Experience with enzyme replacement therapy in children with late-onset Pompe disease diagnosed via newborn screening in the United States.” Molecular Genetics and Metabolism, vol. 141, no. 2, Elsevier BV, 2024, pp. 107886–107886. Crossref, doi:10.1016/j.ymgme.2023.107886.
Huggins E, Nading E, Makhijani N, Blount J, Holland M, Case L, Kishnani P. Experience with enzyme replacement therapy in children with late-onset Pompe disease diagnosed via newborn screening in the United States. Molecular Genetics and Metabolism. Elsevier BV; 2024. p. 107886–107886.
Published In
Molecular Genetics and Metabolism
DOI
ISSN
1096-7192
Publication Date
February 2024
Volume
141
Issue
2
Start / End Page
107886 / 107886
Publisher
Elsevier BV
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences